January 06, 2024 22:53 (London Time)

Cidara Therapeutics

Youtube Subscribe

Sector: Biotechnology

Ticker: CDTX

Sentiment: 0.891

MarketCap: 70,312,261.0

High: 0.8 Low: 0.76

Open: 0.8 Close: 0.78 Change: -0.02

You're losing the opportunity of using an AI to get informed about Cidara Therapeutics.

Are looking for the most relevant information about Cidara Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Cidara Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cidara Therapeutics are: Cidara, Therapeutics, share, Needham, keep, buy, rating, and the most common words in the summary are: therapeutic, inc, cidara, stock, penny, share, cdtx, . One of the sentences in the summary was: Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. …

Concept Map

Semantic Network

Stock Summary

Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4..

Today's Summary

Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4.67, implying a 253.79% upside from current levels. Cidara Therapeutics (CDTX) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.14 per share. Rezzayo (rezafungin) for the Treatment of Invasive Candidiasis in Adults received European approval for the treatment. Cidara Therapeutics, Inc. presents new data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023. Company announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Today's News

Stock Profile

" Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Analyst consensus on Cidara Therapeutics is a Strong Buy with an average price target of $4.67, implying a 253.79% upside from current levels. Cidara Therapeutics (CDTX) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.14 per share. Rezzayo (rezafungin) for the Treatment of Invasive Candidiasis in Adults received European approval for the treatment. Cidara Therapeutics, Inc. presents new data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023. Company announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)"

Keywords

The game is changing. There is a new strategy to evaluate Cidara Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cidara Therapeutics are: Cidara, Therapeutics, share, Needham, keep, buy, rating, and the most common words in the summary are: therapeutic, inc, cidara, stock, penny, share, cdtx, . One of the sentences in the summary was: Needham keeps their buy rating on cidara therapeutics (cdtx) - tipranks.com.com. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #inc #cidara #stock #penny #share #cdtx.

February 24, 2024 7:05 (London Time)